Objective: Although it is believed that sodium-driven acid-base transport plays a central role in the development of the reperfusion results show that a neutralizing antibody raised against the human heart electrogenic Na / HCO cotransporter (hhNBC) blocked the 3 recovery of pH after acidic pulse both in HEK-293 cells expressing hhNBC and in rat cardiac myocytes demonstrating the presence of an electrogenic NBC in rat cardiac myocytes similar to hhNBC. Administration of anti-NBC antibody to ischemic-reperfused rat hearts markedly protects systolic and diastolic functions of the heart during reperfusion. Furthermore, using a quantitative real-time RT-PCR (TaqMan) and Western blot analysis we demonstrated that in human cardiomyopathic hearts, mRNA and protein levels of hhNBC 1 2 increase, whereas mRNA levels of the electroneutral Na / HCO cotransporter (NBCn1) remain unchanged. Conclusion: Our data 3 provide evidence that inhibition of hhNBC, whose role in cardiac pathologies could be amplified by overexpression, represents a novel therapeutic approach for ischemic heart disease. for 40-50% in ventricular myocardium [10, 11]. Alteration
Isabelle Berrebi-Bertrand , Xavier Martin , Mark O. Bevensee , Walter F. Boron , a of NBC activity could thus play a major role in pathologiWestern-blot experiments using anti-hhNBC specific antical situations such as myocardial ischemia, where intracelbodies. lular proton generation is substantially elevated.
For cardiac myocyte experiments, rats were anesthetized Functional and molecular studies indicate the presence and the heart was rapidly removed. Myocytes were isolated of at least two NBCs in the heart. An electroneutral NBC as previously described [22] . has been described in sheep cardiac Purkinje fibres [6] and in guinea-pig ventricular cells [10] , whereas an elec-2.3. Polyclonal antibodies trogenic NBC has been characterized in cat papillary muscle and rat cardiac myocytes [11] [12] [13] . Following the The deduced amino acid of hhNBC protein was anaexpression cloning of an electrogenic NBC from amlysed for highly antigenic regions using the Jameson-Wolf phibian kidney [14] , other electrogenic NBCs have been antigenic index. A peptide representing amino acids 629-cloned from mammalian kidney [15, 16] , pancreas [17] , 644 of hhNBC was synthesized (Peptide Synthesizer heart [18] and brain [19] . More recently, electroneutral Model 431A, Applied Biosystems), purified and conjuNBCs (NBCn1-A-NBCn1-D) cloned from rat smooth gated to keyhole limpet hemocyanin, using benzidine as muscle have also been shown to be expressed in heart [20] .
the coupling agent. Fourteen-week-old New Zealand rabHere, we show that, in contrast to the electroneutral bits (two animals per peptide) were injected on day 0 with cotransporter NBCn1-A [20] (also known as NBC3 [21] ), peptide-carrier conjugate (150 mg / injection) in complete the electrogenic hhNBC is overexpressed in hearts from
Freund's adjuvant, and every 2 weeks thereafter with patients with heart failure. We also demonstrate that peptide-carrier conjugate (50 mg / injection) in incomplete specific inhibition of hhNBC with a polyclonal antibody Freund's adjuvant. Animals were bled 7 days after boosts raised against an hhNBC-specific peptide is effective at (days 39, 69 and 95) and sera were tested at various reducing post-ischemic dysfunction in isolated rat hearts.
dilutions on ELISA plates coated with unconjugated Thus, the specific inhibition of hhNBC could represent a peptide. major advance to the treatment of ischemic heart disease, especially in patients with cardiomyopathy.
Expression-pattern studies
Ventricular samples from failing human hearts were obtained from 10 patients with NYHA class VI terminal 2. Methods heart failure undergoing cardiac transplantation (nine men, one woman, mean age 5063 years). Of these, four patients 2.1. Animals had history of ischemic cardiomyopathy (ICM) and six had dilated cardiomyopathy (DCM). All patients were treated All animals used in the present study received human with diuretics, angiotensin-converting enzyme inhibitors, care in accordance with the principle of NIH guidelines antiarrhythmics, and anticoagulants until the time for (publication no. 85-23) for animal care.
transplantation. Normal RNA and protein microsomes samples were obtained from Clontech and from organ 2.2. Cell culture donor candidates (mean age 37.868.5 years) whose hearts could not be transplanted for non-cardiac reasons. The use Experiments were performed in HEK-293 cells expressof these samples was approved by the Internal Review ing hhNBC and in isolated rat cardiac myocytes. The Committees and the investigation was performed in accomplete coding region of hhNBC (GenBank Accession cordance with the principles outlined in the Declaration of no. AF069510) was cloned into the eukaryotic expression Helsinki. vector pCDNA3.1HisC at the EcoRI site in sense and
The expression level of hhNBC was measured using anti-sense orientation. HEK293 cells stably transfected Northern-blot analysis, real-time quantitative RT-PCR and with sense and anti-sense constructs for hhNBC were Western immunoblotting analysis. Total RNA from the grown in Dulbecco's modified Eagle's medium (Life ventricles of normal hearts, and hearts from patients with Technologies) supplemented with 10% fetal bovine serum, dilated cardiomyopathy (DCM) or ischemic car-10 mM Hepes and penicillin / streptomycin (100 U / ml and diomyopathy (ICM) were extracted using the acid 100 mg / ml, respectively). When cells reached 80% of guanidinium thiocyanate-phenol-chloroform method [23] . confluency, they were transfected with pCDN-hhNBC Real-time quantitative RT-PCR were performed on plasmid, using lipofectamin (Life Technologies, Cergy cDNA generated from 100 ng of total RNA using murine Pontoise, France).
Moloney leukemia virus reverse transcriptase (Life techStably transfected clones were selected by addition of nologies) and random hexamers. For the PCR, we used 200 G418 (1 mg / ml) to the medium. Expression of recombinM of both sense and antisense primers (Genset) as well as nant hhNBC in HEK-293 cells was tested by RT-PCR, 100 nM of TAMRA-labelled primer probe (PE Applied using specific primers for hhNBC (not shown) as well as in Biosystems) in a final volume of 50 ml, the TaqMan PCR core reagent kit, and a ABI PRISM 7700 Sequence tiator (Gould Electronics, Cleveland, OH, USA). Balloon Detection System (PE Applied Biosystems). Sense, antivolume was adjusted to achieve a left ventricular endsense, and probe primers were AAGTAGAAGGCCACdiastolic pressure (LVEDP) of 8-10 mmHg. The volume CATACCATTTA, CCCTGTCTTTCTCTTGTGACGTC, of the LV balloon was kept constant throughout the and CGGAGTCCATGTGCCGAAGAGTTACAG for experiment, so that changes in LVEDP reflect changes in hhNBC; GAGGTCCCTGTTCCAACCAG, ATCGTCCAAdiastolic chamber distensibility [28] . The exponential time TTTCATGGTACTGTG, and ATTGGGTCCAGCGGGCAconstant of left ventricular pressure decay (t) was calcu-AGGC for NBCn1; and GGCCATCCACAGTCTTClated from the linear regression of 2dP/dt versus pressure, TGG, GGCCATCCACAGTCTTCTGG, and ACCACAassuming that the asymptote of the left ventricular relaxa-GTCCATGCCATCACTGCCA for GAPDH (to account tion is zero [29] . All measurements were recorded on a for variability in the initial quantities of cDNA). For thermal multichannel recorder (Gould Electronics) and hhNBC or GAPDH, serial dilutions of plasmid DNA or transferred to computer for analysis. Coronary flow was genomic DNA was amplified to generate standard curves monitored by collecting coronary sinus effluent. All hearts and to assess PCR efficiency. Results are presented as were initially equilibrated for 30 min after which, zerocycle threshold (C ), i.e., the PCR cycle number at which flow or low-flow (0.5 ml / min) global ischemia was T exponential PCR-generated fluorescence is first detected; induced for either 30 or 60 min followed by a reperfusion. the lower the C , the higher the expression. Northern blot T 1 analysis was done on 2 mg of poly A RNA using standard 2.7. Lactate dehydrogenase release methods [24] .
In immunoblotting experiments, the polyclonal antibody Lactate dehydrogenase (LDH) leakage from the myocartypically recognized a 137-kDa band, which is believed to dium was measured, using an enzymatic assay kit (Boehbe glycosylated hhNBC.
ringer-Mannheim, Germany), in the coronary effluent collected during reperfusion. The activity of LDH was 2.5. Intracellular pH measurement normalized against the wet weight of heart and coronary flow rate as U / min per g wet weight. The absorbance was HEK-293 cells were loaded with 1 mM of BCECF-AM read at 334 nm using a Beckman DU-640 spectrophotome-[25], the acetoxymethyl ester of the pH-sensitive fluorester. cent dye 29,79-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM, Molecular Probes, Eugene, USA) for 30 2.8. Statistics min at 378C. pH was measured in a thermostatically i controlled holding chamber (378C) in a Delta Scan dualAll data are expressed as the mean6S.E.M. of n excitation spectrofluorometer (Photon Technology Internapreparations. Statistical comparisons were made using tional, South Brunswick, NJ, USA). The cells were coneither Student's t-test or one-way analysis of variance. tinuously superfused with Tyrode buffer solution. Fluorescence was detected in individual cells using excitation wavelengths of 440 and 490 nm at an wavelength emission 3. Results of 535 nm. The pH calibration was generated using the i KCl / nigericin technique [26] . The initial rate of pH 3.1. Functional evidence for hhNBC in cardiac cells i recovery from an acid load was calculated by fitting a line to the first 2 min of the pH recovery. Polyclonal antibodies raised against an extracellular loop i of hhNBC were generated and used for both Western-blot 2.6. Isolated-heart perfusion experiments and functional studies, either in NBC-transfected HEK-293 or in isolated cardiomyocytes. The antiMale Wistar rats (280-320 g) were anesthetized by NBC antibody detected a single, |137-kDa band in intraperitoneal injection of sodium thiopental (50 mg hhNBC-transfected HEK-293 cells, but nothing in non-21 kg ). Hearts were then cannulated via the aorta and transfected cells (Fig. 1a) . Similarly, the antibody detected perfused using the Langendorff technique with Krebsa single band of about 137 kDa in microsomal fractions Henseleit buffer of the following composition (in mM): from rat cardiac tissue (Fig. 1b) with a 95%O / 5%CO gas mixture and maintained at trogenic transport reported previously [11] . 2 2 378C. A water-filled latex balloon fixed to a pressure The functional activity of the polyclonal anti-NBC transducer was inserted into the left ventricle for the antibody was assessed in NBC transfected HEK-293 cells determination of left ventricular developed pressure (Fig. 1c ) and in isolated cardiomyocytes (Fig. 1d) . In both 1 (LVDP) and heart rate as previously described [27] . cases, we acidified the cells with an NH prepulse [30] . 4 Positive and negative dP/dt were obtained with a differenAnti-NBC slowed the pH recovery in hhNBC-transfected
leading via Na / Ca exchange to a secondary increase in 21 [Ca ] , and thus cell damage. Several studies have i reported that inhibiting NHE protects against myocardial injury following ischemia-reperfusion [5] . We previously suggested that additional mechanisms, including NBC, could also be involved [31] . To elucidate the role of hhNBC in post-ischemic contractile dysfunction, we investigated the effect of the neutralizing antibody in isolated perfused rat hearts subjected to either (i) 30-min zero-flow ischemia followed by 20-min reperfusion, or (ii) 60-min low-flow ischemia and 30-min reperfusion. NBC polyclonal antibody or pre-immune serum (1:1000 in Krebs buffer solution) was added to the perfusate 15 min before initiating ischemia, and was maintained throughout the experiment, during which serial measurements of hemodynamic parameters were performed. Basal pre-ischemic values of cardiac function were not affected by the presence of anti-NBC (Table 1) . 6.5160.14; n55). The pH recovery measured in cells unaffected by the antiserum (Fig. 2b-d ).
i transfected with antisense cDNA (0.06260.011 pH / min at On reperfusion, the diastolic parameter LVEDP inpH 56.7060.03; n515) was not changed by anti-NBC creased markedly in control hearts (Fig. 2a) preimmune serum had no effect. Taken together, these limits post-ischemic contracture (Fig. 2a) , and markedly results show that the antiserum functionally inhibits increased LVDP (Fig. 2b) . The other parameters measured hhNBC, which is responsible for more than half of the pH to characterise the cardiac function recover more rapidly i recovery in isolated cardiomyocytes. and more extensively in anti-NBC-treated hearts compared to that in controls. For example, dP/dt and dP/dt max min
hhNBC is involved in post-ischemic dysfunction
reached 79 and 83% of pre-ischemic value, respectively, in less than 15 min of reperfusion in the presence of anti-A well-known consequence of myocardial ischemia is NBC, whereas the control values remained at less than intracellular acidosis. During reperfusion, this low pH 30% of the pre-ischemic value (not shown). Heart rate i 1 activates NHE, which may overload the cell with Na , (Fig. 2c ) completely recovered to pre-ischemic values within the first 5 min of reperfusion, and coronary flow effluent at the time of reperfusion, measured to assess the (Fig. 2d) overshot the pre-ischemic value. Such an increase degree of cell damage following global ischemia and in coronary flow at the time of reperfusion may be related reperfusion, was reduced by anti-NBC treatment (Fig. 4) . to the protection of the cardiac function as usually obThese data suggest that acute anti-NBC treatment imserved with cardioprotective agents.
proved contractile recovery and reduced the degree of contracture or irreversible myocardial injury during post-3.2.2. Low-flow ischemia ischemic reperfusion. During ischemia, LVEDP increased progressively with time ( Fig. 3a) , while LVDP, dP/dt and dP/dt rapidly max min fell to zero (Fig. 3b-d) . In the presence of anti-NBC 3.3. hhNBC expression is increased in human antibody, LVEDP increased more slowly during the iscardiomyopathic hearts chemic period (Fig. 3a) , and the complete abolition of cardiac function as determined by LVDP, dP/ dt and Previous work showed that hhNBC is not measurably max dP/dt , tended to be delayed ( Fig. 3b-d) . expressed in kidney, but is highly expressed in pancreas min During reperfusion, treatment with antiserum caused all [17, 18] and, to a much lesser extent, in heart [18] . To gain cardiac function parameters to recover substantially more additional insight into the role of the electrogenic NBC in towards pre-ischemic values than no treatment (Fig. 3a-d) .
human cardiac pathologies, the expression pattern of At the end of the reperfusion period, t (an index of hhNBC was measured in normal and in cardiomyopathic isovolumic relaxation time) was 99626 ms in treated hearts. Probes specific for the N-terminus unique to hearts, but 277678 ms in controls. Furthermore, the extent hhNBC were used for Northern experiments illustrated in of lactate dehydrogenase (LDH) release into the coronary Fig. 5a . As previously demonstrated, hhNBC mRNA was not detected in the kidney, but a very faint band at 7.5 kb By densitometry, the signal intensity increased from an was observed in normal hearts. In contrast, easily detectaverage of 1.060.3 arbitrary units in control preparations able bands were noted in RNA preparations in either left or to 6.961.0 in heart failure (P,0.05). right ventricle from patients with end-stage heart failure.
In an additional set of experiments, we used real-time quantitative RT-PCR to investigate expression of hhNBC and NBCn1 in hearts from patients with ischemic and dilated cardiomyopathies. This approach, which is more sensitive than Northern analysis, easily detected hhNBC in normal heart (Fig. 5b) . Moreover, in cardiomyopathic hearts, the cycle threshold for detecting hhNBC was significantly reduced. Therefore, confirming the results obtained by Northern analysis, both dilated and ischemic cardiomyopathy increase the expression of hhNBC. The number of copies per ng of total RNA increased from 11546183 in normal to 18776200 in ischemic cardiomyopathy and to 22626156 in dilated cardiomyopathy. In contrast, cardiomyopathy did not change the cycle threshold for detecting NBCn1 (Fig. 5c) . (2) total RNA from kidney (Clontech); (3,4) polyA1 mRNA from normal Heart (Clontech); (5-9) total RNA extracted from left ventricle specimens from human heart with terminal heart failure (donor hearts); (10-16) total RNA extracted from right ventricle specimens from human heart with terminal heart failure (donor hearts). hhNBC (b) and NBCn1 (c) mRNA expression was compared from the left ventricle of human normal, ischemic (ICM) and dilated (DCM) cardiomyopathic hearts using real time quantitative RT-PCR. Data are corrected for individual variation using GAPDH expression and results are expressed as cycle threshold. Western blot (d) showing hhNBC expression levels in normal (N) and failing (HF) human left ventricular myocardium. Representative signals from two normal and two failing hearts are shown.
Discussion
changer acidifies the cell, activation of the NHE and the NBC alkalinises it. Furthermore, Vandenberg and colThe regulation of pH in cardiac myocytes primarily leagues suggested that during myocardial ischemia metai depends on the activity of at least three membrane bolic washout, i.e., lactate and CO , may represent a
transporters. While activation of the Cl -HCO exsignificant contributor to net pH recovery [32] . Although the role of NHE in cardiac pathophysiological states has NHE [34] but we could hypothesize that the electrogenic been widely investigated [5] , the role of NBC had been NBC might contribute to the higher incidence of ischemiaundefined. Characterization of NBC isoforms is still in its related arrhythmias in the failing heart [35] . early stage, and both electroneutral [6, 10] and electrogenic
The protection afforded by inhibiting hhNBC was Although the molecular mechanism responsible for such a have been identified in human heart. Here, we have pronounced protection is not defined yet, we suggest that a demonstrated, at the protein level, that the electrogenic reduction of intracellular calcium cycling may be involved, NBC is expressed in both rat heart (Fig. 1b) and human as evidenced by the reduced contracture during both heart (Fig. 5d) , and that the specific inhibition of this ischemia and reperfusion. During ischemia and reperfuelectrogenic transporter using a neutralizing antibody sion, intracellular acidosis leads to an activation of NBC 1 protects the heart against ischemic injury. associated to an increase Na influx. In this respect, recent Antibodies to synthetic peptides based on amino acid data clearly indicated that during no-flow ischemia, sequences of a protein have proven useful for understandmyocardial [Na] markedly increased in perfused rat hearts i 1 121
ing the structure, analyzing the molecular forms and [36] . Increasing [Na ] will increase reverse Na / Ca anti-Cl / HCO (AE1 isoform) raised against loops of the 3 cardiac function, especially diastolic function, to deteriortransporter significantly decreased the exchange function ate during ischemia and reperfusion. We showed that antiof the AE1 protein [33] . We developed polyclonal anti-NBC exerts beneficial effects during ischemia but more bodies raised against an immunogenic region of hhNBC.
profoundly during early postischemic reperfusion, espeBecause the synthetic peptide had the same sequence as cially, the heart rate returned to normal immediately at the hhNBC between amino acids 629 and 644, the antibodies onset of reperfusion. In this respect, it has been reported are likely to recognise an extracellular loop of the protein.
that certain interventions at the time of reperfusion or Consistent with our knowledge that the amino acid sebefore ischemia may be expected to reduce reperfusion quence of this loop in hhNBC [17, 18] is extremely similar injury or stunning. The reperfusion in isolated ferret hearts to the homologous region in the electrogenic rat NBCs undergoing zero-flow ischemia, with acidic perfusate pre- [15, 19] , the anti-NBC antibody recognised a single band in vent subsequent contractile dysfunction [37] . Moreover, both HEK-293 cells expressing hhNBC and in rat cardiac using isolated perfused hearts it was reported that reperfutissue. Because there is little similarity between the sion with acidotic buffer (pH 6.4 or 6.6) attenuated the hhNBC peptide used to produce the antibody and the 1 21 gain in tissue Na and Ca contents [38] . Finally, homologous region of the electroneutral NBCs [20] reoxygenation injury produced in rat neonatal cardiac (12.5% identity), and because our antibody did not recogmyocytes has been shown to be attenuated when restoranize a second band in Western blots, it is unlikely that the 1 2 tion of oxygen was carried out with acidotic medium [39] . antibody inhibits the electroneutral Na / HCO cotrans- porter. Furthermore, the anti-NBC antibody neutralized during ischemia-reperfusion remain necessary, our results NBC activity in both hhNBC-transfected HEK-293 and suggest that anti-NBC-induced protection seems at least in isolated rat cardiac myocytes. Taken together, these results part to be mediated by reduction of the ischemia-resuggest that an electrogenic NBC is expressed and func-21 perfusion-induced Ca overload since the time of onset tional in rat cardiac cells, as previously suggested from and amplitude of ischemia-and reperfusion-induced conelectrophysiological approaches [12] . We further demontracture were significantly reduced compared to the nonstrated that, in contrast to what we observed for the treated heart. Because hhNBC is overexpressed in carelectroneutral NBC, the expression level of hhNBC, while diomyopathic hearts we could hypothesize that this transrather low in normal human heart, is increased in carporter may play a more pronounced role in patients with diomyopathic hearts. It could be speculated that the heart failure. In particular, upregulation of hhNBC expresincreased expression of the electrogenic NBC would alter sion could contribute to both mechanical dysfunction and the electrophysiological and contractile parameters of the cardiac cells.
arrhythmogenesis in the failing heart. Obviously this needs Although this remains to be further investigated, NBC to be further investigated with the aim of determining 
